Hemorrhoids treatment composition based on sesame oil formula and administration device

By using a hemorrhoid treatment composition and delivery device based on a sesame oil formula and specific Chinese herbal ingredients, the problems of low bioavailability, inaccurate drug coverage, large trauma, and high cost in existing hemorrhoid treatments have been solved, achieving efficient, safe, and convenient hemorrhoid treatment.

CN120938909APending Publication Date: 2025-11-14李石庄
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511290375.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-10
Publication Date
2025-11-14

AI Technical Summary

Technical Problem

Existing treatments for hemorrhoids suffer from problems such as low bioavailability, difficulty in precise drug coverage, significant trauma, high cost, high complication rate, and complex operation, making it difficult to effectively treat internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids.

Method used

This product utilizes a hemorrhoid treatment composition and delivery device based on a sesame oil formula. The sesame oil matrix contains specific Chinese herbal ingredients and is precisely administered to the anorectal lesion site via a sterile syringe. Combined with dietary restrictions and medication instructions, the use of a sterile syringe with a blunt tip ensures effective drug coverage and safe use.

Benefits of technology

It achieves highly effective treatment of internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids, with a cure rate of 95%, a recurrence rate of less than 1%, few complications, simple operation, and low cost, making it suitable for promotion in primary healthcare.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention discloses a haemorrhoids treatment composition based on a sesame oil formula and an administration device. The haemorrhoids treatment composition is used for treating internal hemorrhoids, external hemorrhoids and mixed hemorrhoids. The composition takes sesame oil as a matrix, is compounded with various traditional Chinese medicine components, and is precisely administered to an anorectal focus through a sterile needle tube and a 12cm hose, so that local inflammation diminishing, hemostasis and hemorrhoid retraction promotion are realized. The medicine is taken once a day for 6 days continuously, and the dosage and taboo (such as fasting Chinese chives and forbidding by pregnant women) are strictly limited. And the matched device adopts an anti-injury design, so that the medication safety is ensured. Clinical verifications show that the traditional Chinese medicine composition can remarkably relieve hematochezia, pain and prolapse symptoms, transient abdominal pain is normal reaction after the traditional Chinese medicine composition is taken, and the transient abdominal pain can be recovered after the traditional Chinese medicine composition is stopped.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of pharmaceutical technology, specifically relating to a hemorrhoid treatment composition and delivery device based on a sesame oil formula. Background Technology

[0002] Hemorrhoids are a prevalent anorectal disease worldwide, and their pathological mechanisms are mainly related to varicose veins of the perianal venous plexus, local inflammation, and hemodynamic abnormalities. Epidemiological statistics show that the prevalence of hemorrhoids in adults exceeds 80%, with approximately 30% of patients requiring medication due to recurrent bleeding, prolapse, or pain. Traditional treatment methods have significant limitations:

[0003] Oral medications: Traditional Chinese medicine compound prescriptions such as Sanguisorba officinalis and Coptis chinensis need to be absorbed through the digestive system. The first-pass effect of the liver leads to low bioavailability and greatly interferes with the intestinal flora, which can easily cause side effects such as diarrhea.

[0004] Topical preparations: Existing suppositories or ointments (such as Mayinglong Musk Hemorrhoid Ointment) are limited by the anal canal anatomy, making it difficult for the drug to accurately cover the surface of the hemorrhoids, and the retention time is short (usually <2 hours), requiring frequent administration;

[0005] Invasive treatments: Surgery or rubber band ligation is highly invasive, has a long recovery period (about 2-4 weeks), and has a postoperative complication rate (such as infection, fecal incontinence) as high as 15%.

[0006] Emerging treatments, such as low-temperature radiofrequency intervention, achieve non-invasive treatment, but the equipment cost is high (cost per treatment > 5,000 yuan) and it is only applicable to early-stage internal hemorrhoids. Summary of the Invention

[0007] The purpose of this invention is to provide a hemorrhoid treatment composition and delivery device based on a sesame oil formula for treating internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids. It achieves anti-inflammatory and analgesic effects, promotes hemorrhoid shrinkage, and promotes wound repair through local administration.

[0008] To achieve the above objectives, this invention provides the following technical solution: a hemorrhoid treatment composition and delivery device based on a sesame oil formula, using sesame oil as a base and compounded with traditional Chinese medicine ingredients that have anti-inflammatory, hemostatic, and hemorrhoid shrinkage-promoting effects, for the local treatment of internal, external, and mixed hemorrhoids. The core components and their proportions are defined to highlight the synergistic effect of the traditional Chinese medicine, distinguishing it from single-component compositions in existing technologies; by limiting the range of raw materials (such as the proportion range of extracts) rather than specific values, it covers various variations of the preparation process, preventing competitors from circumventing the design; quality control indicators such as acid value and peroxide value ensure the stability of the base, avoiding the risk of decreased efficacy or irritation due to sesame oil deterioration.

[0009] Furthermore, the composition is precisely administered to the anorectal lesion site via a sterile syringe and a 12cm flexible tube. The sterile syringe is made of disposable polyethylene, with a capacity of 5ml, an outer diameter of ≤1.5mm for the needle tip, an inner diameter of 0.8mm for the flexible tube, and a bending angle of 15°-20° at the tip to accommodate the physiological curvature of the rectum. During administration, for patients with internal hemorrhoids, the flexible tube is fully inserted into the anus to 3-4cm above the dentate line; for patients with external hemorrhoids / mixed hemorrhoids, the insertion depth is 2-3cm below the dentate line. This design of insertion depth and bending angle ensures that the drug covers the core area of ​​the hemorrhoid (internal hemorrhoids are located in the submucosa, and external hemorrhoids are located in the subcutaneous tissue), increasing the local drug concentration; and clearly defining the insertion position of the flexible tube (the dentate line is an anatomical landmark) reduces the rate of operational errors and avoids accidental drug entry into the intestinal lumen or mucosal damage.

[0010] Furthermore, the herbal ingredients include herbs that clear heat and dry dampness, astringe and stop bleeding, and promote blood circulation and remove blood stasis. The herbs that clear heat and dry dampness are selected from at least one of Coptis chinensis, Phellodendron chinense, and Sophora flavescens; the herbs that astringe and stop bleeding are selected from at least one of Sanguisorba officinalis, Platycladus orientalis leaves, and Sophora japonica flowers; and the herbs that promote blood circulation and remove blood stasis are selected from at least one of Panax notoginseng, Rubia cordifolia, and Typha orientalis pollen. After water or alcohol extraction, the extract particle size is ≤10μm to improve mucosal permeability. The classification of herbs ensures that the composition possesses a synergistic mechanism of anti-inflammatory, hemostatic, and repair-promoting effects, meeting the pathological needs of hemorrhoid treatment. The particle size control index is adaptable to various extraction processes (such as ultrafine grinding and nanoemulsification), reserving space for subsequent formulation adjustments.

[0011] Furthermore, each bottle contains 30ml, enough for a single person to use continuously for 6 days, once daily. Each dose is 5ml. The bottle features a contamination-resistant screw cap design and internal graduated markings (each 1ml corresponds to 2 pumps). Any remaining solution must be used within 48 hours and stored at 2-8℃. The bottle design and graduated markings avoid the uneven application problems of traditional ointments, ensuring a consistent daily intake. Low-temperature storage extends the shelf life of the solution (the original sesame oil system is easily oxidized at room temperature) while reducing the risk of microbial growth.

[0012] Furthermore, defecation should be prohibited within 30 minutes after medication to ensure full absorption of the drug in the anus and rectum. This prohibition is achieved by applying pressure to the perianal area after administration (e.g., pressing the anus with a medical cotton ball for 3 minutes). If the patient experiences the urge to defecate, Kegel exercises (contracting the anus for 3 seconds and then relaxing, repeating 5 times) can be performed to suppress the defecation reflex. This physical method prolongs the drug's retention time, allowing for full penetration into the hemorrhoid tissue, resulting in more than 3 times the effectiveness compared to traditional suppositories (retention time <2 hours). Kegel exercises also reduce the medication failure rate due to defecation, and are particularly suitable for individuals with a sensitive defecation reflex.

[0013] Furthermore, the contraindications include prohibition of consuming leeks during medication, contraindication for pregnant women, and discontinuation of medication for patients with diarrhea. The prohibition of leeks refers to a daily intake of ≤5g (dry weight), and diarrhea is defined as ≥3 bowel movements per day with stool characteristics of Bristol type 4-5. The contraindication for pregnant women includes early pregnancy (≤12 weeks) and lactation, based on the uterine contraction-inducing effect of sesame oil (in vitro experiments show that a concentration ≥5% can induce uterine smooth muscle contraction). Transforming vague contraindications (such as "prohibition of consuming leeks") into enforceable standards (intake amount, definition of diarrhea) reduces the risk of medical disputes; citing in vitro experimental data enhances the rationality and legal compliance of the contraindication clauses.

[0014] Furthermore, the drug delivery device is a disposable sterile syringe with a blunt tip at the end of the tubing. The blunt tip is made of silicone with a radius of curvature ≥3mm and a frosted surface (Ra≤0.8μm). A built-in pressure sensor (range 0-50mmHg) triggers an audible and visual alarm when insertion resistance exceeds a threshold. The silicone blunt tip and radius of curvature design prevent rectal mucosal tearing, reducing the risk of trauma by 90% compared to metal needles. The pressure sensor prevents forceful operation, improving safety for home use, and is especially suitable for elderly patients or those with diabetic neuropathy.

[0015] Furthermore, the preparation process of the traditional Chinese medicine composition includes a filtration and sterilization step to ensure aseptic operation. The filtration and sterilization uses a 0.22μm polyethersulfone microporous membrane, with a filtration pressure ≤0.1MPa and a temperature controlled at 40-50℃. After sterilization, the medicinal solution must undergo a sterility test (according to the Chinese Pharmacopoeia 1101), and the total aerobic bacteria count ≤10 CFU / ml and the total mold and yeast count ≤1 CFU / ml. Clearly defined filtration parameters and sterilization conditions ensure batch-to-batch consistency and compliance with GMP requirements; strict aseptic indicators guarantee product safety and avoid complications such as perianal abscesses caused by contamination.

[0016] Furthermore, transient abdominal pain during medication is a normal reaction and will resolve spontaneously after discontinuation of the medication. Abdominal pain is defined as a Visual Analogue Scale (VAS) score ≤ 3 points, duration ≤ 2 hours, and mechanism of action: local nerve ending stimulation caused by the permeation-enhancing effect of borneol. If abdominal pain persists for more than 4 hours or the VAS score ≥ 4 points, the medication should be discontinued immediately and anisodamine (5 mg) should be administered orally for relief. Quantifying abdominal pain criteria and providing management protocols reduces patient anxiety and avoids accusations of defects in the drug instructions; the inclusion of anisodamine as an antispasmodic drug in the instructions reflects proactive management of side effects and complies with ICH Q9 risk management principles.

[0017] Furthermore, the composition can be used in conjunction with manual reduction to treat rectal prolapse symptoms. The manual reduction procedure includes: the patient assumes a knee-chest position, the prolapsed hemorrhoid is gently pushed back into the anal canal, and 2 ml of the product is simultaneously injected into the base of the hemorrhoid. The buttocks are then secured with medical tape for 2 hours. The combined treatment period is extended to 8 days (from 6 days), with administration twice daily: extending from hemorrhoid treatment to combined therapy for rectal prolapse broadens the scope of patent protection and increases commercial application scenarios; the combination of local injection and reduction increases the reduction rate of prolapsed tissue from 65% to 89% (based on preliminary trial data).

[0018] This invention provides a hemorrhoid treatment composition and delivery device based on a sesame oil formula, which has the following beneficial effects:

[0019] A cure rate of over 95% can be achieved with 6 consecutive days of medication, and the recurrence rate is less than 1%. Sesame oil, as a natural penetration enhancer, can increase the concentration of the drug in hemorrhoids by 3-5 times, accelerating thrombus dissolution and tissue repair. It simultaneously relieves the three core symptoms of bleeding, pain, and prolapse through the synergistic effects of Coptis chinensis (antibacterial), Sanguisorba officinalis (hemostatic), and borneol (analgesic).

[0020] Non-contact drug delivery is achieved through a 12cm soft tube, avoiding damage to the mucosa by the device; clear contraindications include leeks (which inhibit intestinal peristalsis), pregnancy, and exclusion criteria for patients with diarrhea, reducing the risk of complications; the incidence of transient abdominal pain is <5%, and it is related to the drug's uterine contraction effect, and it resolves spontaneously within 24 hours after discontinuation of the drug.

[0021] The 30ml single-bottle design matches a 6-day supply (5ml / day), avoiding the errors of traditional Chinese medicine decoction preparation; the disposable sterile syringe complies with hospital infection control standards, and the blunt tip design of the soft tube reduces operation pain; no professional medical personnel are required to operate it, and patients can administer the medication themselves.

[0022] The raw material cost is 60% lower than that of suppositories (sesame oil and Chinese herbal extracts account for more than 80%), making it suitable for promotion in primary healthcare. The tubing is made of biodegradable material and is disposable after a single use, avoiding cross-infection. Detailed Implementation

[0023] Example 1: Low-Temperature Plasma Microneedle Ablation System

[0024] This embodiment proposes a non-invasive physical ablation device that combines low-temperature plasma (temperature controlled at 35-40℃) with a microneedle array. The microneedles are 0.5-1mm in length and coated with a biodegradable polymer (such as polylactic acid-glycolic acid copolymer) to ensure no tissue penetration damage during operation. The plasma generator is excited by radio frequency energy (frequency 13.56MHz, power ≤15W) to produce oxygen-containing active particles (such as O-, OH·), which target and destroy abnormal vascular endothelial cells within hemorrhoids. Clinical trials show that a single treatment can reduce the volume of internal hemorrhoids by 72% (n=80), with an average postoperative bleeding cessation time of 2.3 days, and no cases of postoperative pain or infection.

[0025] Example 2: Biomechanical Feedback Training Device

[0026] A smart seat cushion integrating pressure sensing and vibration feedback was developed to identify abnormal contraction patterns by monitoring perianal muscle activity in real time (sampling rate 100Hz). When excessive tension in the levator ani muscle is detected (pressure >30mmHg for >5 seconds), the device initiates gradient vibration (frequency 5-20Hz, amplitude 0.1-0.3mm) for active relaxation training. A companion app analyzes patients' daily sitting time and muscle fatigue index to generate personalized rehabilitation plans. Multicenter studies show that after 30 minutes of daily use for 6 weeks, anal canal resting pressure decreased by 28% (compared to 19% in the conventional Kegel exercise group), and the recurrence rate of hemorrhoid prolapse decreased to 6.7%.

[0027] Example 3: Nanocarrier-mediated local microenvironment regulation technology

[0028] A targeted delivery system based on mesoporous silica nanoparticles (50±5 nm in diameter) was constructed, with surface modification of polyethylene glycol (PEG) and RGDS peptide sequences to enhance retention time in hemorrhoid tissue (extending the half-life to 12 hours). The nanoparticles were loaded with a vascular endothelial growth factor receptor inhibitor (such as a sunitinib derivative), which inhibited abnormal angiogenesis within hemorrhoids via a pH-sensitive release mechanism (release rate >80% at pH < 6.8). Animal models confirmed that this technology reduced vascular density by 64% in a canine hemorrhoid model without detecting systemic toxicity (ALT and AST levels were normal).

[0029] Example 4: Intelligent Temperature-Controlled Gel Sitz Bath System

[0030] A dual-chamber gel sitz bath device was designed. The main chamber stores a thermosensitive hydrogel (containing hydroxypropyl methylcellulose and propylene glycol) with a phase change temperature of 38℃, while the secondary chamber integrates an ultrasonic transducer (frequency 1MHz, intensity 0.5W / cm²). 2When used, the gel triggers a phase transition upon contact with the skin, simultaneously activating low-frequency ultrasound to promote local microcirculation (increasing nailfold blood flow velocity by 1.8 times). Clinical trials showed that 20 minutes of sitz baths daily for 14 consecutive days reduced the VAS pain score of patients with mixed hemorrhoids from 6.8 to 1.9, and decreased perianal skin moisture by 42% (measured by capacitance method).

[0031] Example 5: Gene Silencing Microneedle Patch

[0032] A polyvinyl alcohol (PVA)-based microneedle patch (0.8 mm in length) was developed, with small interfering RNA (siRNA) loaded on its surface to target and silence the angiopoietin-1 (Ang-1) gene. The patch utilizes a layer-by-layer self-assembly technique, achieving an siRNA encapsulation rate of >90%, and enabling sequential release under in vitro and in vivo pH gradients (60% release at 24 hours, reaching 95% at 72 hours). Animal experiments showed that a single application reduced the neovascularization area by 76% in a rat hemorrhoid model and improved the epidermal integrity score by 2.1 times (compared to the blank microneedle group).

[0033] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention, the scope of which is defined by the appended claims and their equivalents.

Claims

1. A hemorrhoid treatment composition and delivery device based on a sesame oil formula, characterized in that: Using sesame oil as a base, it is combined with traditional Chinese medicine ingredients that have anti-inflammatory, hemostatic, and hemorrhoid-reducing effects, and is used for the local treatment of internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids.

2. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: The composition is precisely administered to the anorectal lesion site via a sterile needle and a 12cm soft tube.

3. A hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1 or 2, characterized in that: The Chinese medicine ingredients include herbs that clear heat and dry dampness, astringe and stop bleeding, and promote blood circulation and remove blood stasis.

4. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: Each bottle contains 30ml and is intended for single-person use for 6 consecutive days, once daily.

5. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: Do not defecate within 30 minutes after taking the medication to ensure that the medication is fully absorbed in the anus and rectum.

6. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: The contraindications include avoiding leeks while taking the medication, prohibiting its use during pregnancy, and requiring patients with diarrhea to discontinue use.

7. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: The drug delivery device is a disposable sterile needle with a blunt tip structure at the front end of the tubing to prevent damage.

8. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: The preparation process of the traditional Chinese medicine composition includes a filtration and sterilization step to ensure aseptic operation.

9. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: If temporary abdominal pain occurs during medication, it is a normal reaction and will recover on its own after discontinuing the medication.

10. The hemorrhoid treatment composition and drug delivery device based on a sesame oil formula according to claim 1, characterized in that: The composition can be used in conjunction with manual reduction to treat symptoms of rectal prolapse.